WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Transplant Product Efficacy Framework 20140115 v6, Banff grade is staged as IIB, defined time points including 12 months, Estimated GFR (eGFR) accounts for Serum Creatinine (SCr), Banff grade is staged as IIA, Study treatments include Zortress, EBV increases risk for PTLD (post-transplant lymphoproliferative disorder), Study treatments are given in Dosages, Glomerular Filtration Rate (GFR) is associated with Cardiovascular (CV) risk, CV death can result from Toxicity, Estimated GFR (eGFR) is correlated with Graft Loss, Transplant Donors have HLA types, Transplant Donors can be Living-non-related, defined time points including 12 months, Banff grade accounts for C4d status, Banff grade accounts for Tubulitis, Observation or Assessment is used to monitor the state of Physiolgoical Process, Observation or Assessment is used to monitor the effectiveness of Therapeutic Intervention, Renal function/ Impairment leads to Never Functioning Graft, Banff grade accounts for Peritubular capillaries (PTC), Graft Loss is assessed at Date of Graft Loss